{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-000909","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2022-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.447684+00:00","generated_at":"2026-06-27T10:26:09.528815+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Azenta Q1 revenue $140M (+18% YoY); completes $3B sale of semiconductor business to THL","bullets":["GAAP diluted EPS from continuing ops $0.04; total diluted EPS $0.58 (incl. $0.54 from discontinued ops).","Life Sciences Products revenue $50M (+10% YoY); Services revenue $90M (+24% YoY).","Closed sale of semiconductor automation business on Feb 1, 2022 for $3.0B cash; net proceeds ~$2.4B; used $50M to extinguish debt.","Q2 FY2022 guidance: revenue $137-147M; non-GAAP EPS $0.07-0.15; GAAP EPS ($0.04)-$0.04."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-000909","json":"https://secwatch.observer/filing/0001558370-22-000909.json","markdown":"https://secwatch.observer/filing/0001558370-22-000909.md","text":"https://secwatch.observer/filing/0001558370-22-000909.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000155837022000909/0001558370-22-000909-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000155837022000909/azta-20220208x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T10:26:09.528815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}